<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02230410</url>
  </required_header>
  <id_info>
    <org_study_id>14-004771</org_study_id>
    <nct_id>NCT02230410</nct_id>
  </id_info>
  <brief_title>Cryo Balloon for Residual Barrett's Esophagus</brief_title>
  <acronym>Cryoballoon</acronym>
  <official_title>CryoBalloon Focal Ablation System for Residual Barretts Esophagus Post Ablation; a Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>C2 Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the response of persistent Barrett's Esophagus and/or dysplasia to focal cyro
      ablation .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational study of patients undergoing clinically indicated focal cryo ablation
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>eradication of barrett's esophagus and/or dysplasia</measure>
    <time_frame>3 to 6 months post treatment</time_frame>
    <description>Surveillance endoscopy with 4-quadrant biopsies every 1 cm from the gastric cardia, proceeding proximally at the length of the original BE lesion/s will be performed per standard clinical practice at 3 or 6 months post ablation. The presence of Barrett's Esophagus and degree of dysplasia will be confirmed by histopathologic diagnosis</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Barrett's Esophagus</condition>
  <arm_group>
    <arm_group_label>focal cryo ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in this pilot study 10 subjects with residual barrett's esophagus (less than 3 cm) post ablation will under go one CryoBalloon Focal Ablation treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CryoBalloon Focal Ablation</intervention_name>
    <arm_group_label>focal cryo ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligible patients for enrollment in this study must fulfill all of the following criteria:

          1. Age &gt; 18 years old

          2. Able to provide informed consent

          3. Patients with unifocal or multifocal BE with 2 cm who have failed at least 2 serial
             RFA or other endoscopic therapy such as Endoscopic Mucosal resection,

        Exclusion from the study with any of the following:

          1. Age younger than 18 years old

          2. Presence of esophageal varices

          3. Esophageal stricture precluding passage of an endoscope

          4. Inability to provide informed consent

          5. Esophageal cancer (T2 and above)

          6. Coagulopathy with INR &gt; 2.0, thrombocytopenia with platelet counts &lt; 50,000

          7. pregnancy (if required a pregnancy test would be performed as part of routine clinical
             care)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mayo.edu/research/labs/barretts-esophagus/overview</url>
    <description>research lab web site related information</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2014</study_first_submitted>
  <study_first_submitted_qc>August 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2014</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kenneth K. Wang</investigator_full_name>
    <investigator_title>VanCleve Professor of Gastroenterology Reserach</investigator_title>
  </responsible_party>
  <keyword>Barrett's</keyword>
  <keyword>high grade dysplasia</keyword>
  <keyword>ablation</keyword>
  <keyword>cyrotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Barrett Esophagus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

